Cargando…
Mammographic density and molecular subtypes of breast cancer
BACKGROUND: Gene expression profiling has led to a subclassification of breast cancers independent of established clinical parameters, such as the Sorlie–Perou subtypes. Mammographic density (MD) is one of the strongest risk factors for breast cancer, but it is unknown if MD is associated with molec...
Autores principales: | Eriksson, L, Hall, P, Czene, K, dos Santos Silva, I, McCormack, V, Bergh, J, Bjohle, J, Ploner, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389424/ https://www.ncbi.nlm.nih.gov/pubmed/22644308 http://dx.doi.org/10.1038/bjc.2012.234 |
Ejemplares similares
-
Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer
por: Eriksson, Louise, et al.
Publicado: (2019) -
Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk
por: Sovio, U, et al.
Publicado: (2014) -
Mammographic density and survival in interval breast cancers
por: Eriksson, Louise, et al.
Publicado: (2013) -
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients
por: Thorén, Linda, et al.
Publicado: (2021) -
Determinants of Mammographic Density Change
por: Azam, Shadi, et al.
Publicado: (2019)